Luminex Corp (LMNX)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Luminex Corp (LMNX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010896
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:64
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Luminex Corp (Luminex) is a medical devices company which develops, manufactures and markets proprietary biological testing technologies. The company offers wide range of products including instruments, assays, reagents and accessories, software and replacement parts. Its proprietary technologies consist of xMAP technology, xTAG and MultiCode technology. Luminex offers its products to various markets such as clinical diagnostics; pharmaceutical drug discovery; biomedical research including personalized medicine, genomic and proteomic research, biodefense research and food safety. The company sells its products through direct sales channel and strategic distribution partners in North America, Europe and Asia-Pacific. Luminex is headquartered in Texas, the US.

Luminex Corp (LMNX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Luminex Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Luminex Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Luminex Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Luminex Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Luminex Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Luminex Corp, Medical Equipment, Deal Details 12
Partnerships 12
Natural Molecular Testing Enters Into Licensing Agreement With Luminex 12
Merck Enters Into Licensing Agreement With Luminex To Develop Companion Diagnostic Device 13
Genetic Analysis Enters into Agreement with Luminex 14
Luminex Enters into Distribution Agreement with Bio-Techne 15
Affymetrix Enters into Distribution Agreement with Luminex 16
TheraDiag Enters Into Distribution Agreement With Luminex For xTAG RVP And xTAG GPP 17
Luminex Extends Distribution Agreement With EMD Millipore 18
Nanosphere Enters Into Distribution Agreement With Hitachi High-Technologies 19
Nanosphere Enters Into Co-Marketing Agreement With Thermo Fisher For Verigene Products 20
Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX 21
Luminex Enters Into Distribution Agreement With Life Technologies 22
Luminex Enters Into An Agreement With Partners HealthCare 23
Equity Offering 24
Nanosphere Raises USD10 Million in Public Offering of Shares 24
Nanosphere to Raise USD4.4 Million in Private Placement of Convertible Preferred Stock 26
Nanosphere Raises USD4.4 Million in Private Placement of Series A Convertible Preferred Stock 27
Nanosphere Raises USD20 Million in Public Offering of Shares 28
Nanosphere Completes Public Offering Of Shares For US$30.2 Million 29
Nanosphere Completes Public Offering Of Shares For US$5 Million 31
Nanosphere Completes Public Offering Of Common Stock For US$29 Million 32
Nanosphere Completes Underwritten Public Offering Of US$34.5 Million 33
Asset Transactions 35
Luminex Plans To Sell Newborn Screening Business 35
Acquisition 36
Luminex Acquires Nanosphere in Tender Offer 36
Nanosphere Plans to Sell Itself 38
Luminex Completes Acquisition Of GenturaDx, Molecular Diagnostics Company, For Upto US$60 Million 39
Luminex Completes Acquisition Of EraGen Biosciences 41
Luminex Corp – Key Competitors 42
Luminex Corp – Key Employees 43
Luminex Corp – Locations And Subsidiaries 44
Head Office 44
Other Locations & Subsidiaries 44
Recent Developments 46
Financial Announcements 46
Oct 30, 2017: Luminex Reports Third Quarter 2017 Financial Results 46
Aug 07, 2017: Luminex Reports Second Quarter 2017 Financial Results 47
May 01, 2017: Luminex Reports Record First Quarter 2017 Financial Results; Raises 2017 Financial Guidance 48
Feb 06, 2017: Luminex Reports Fourth Quarter And Full Year 2016 Results 49
Jan 09, 2017: Luminex Announces Preliminary Revenue for Fourth Quarter 2016 and Issues 2017 Revenue Guidance 50
Oct 31, 2016: Luminex Reports Third Quarter 2016 Results; Raises Full Year Guidance 51
Jul 28, 2016: Luminex Reports Second Quarter 2016 Results 52
May 02, 2016: Luminex Reports First Quarter 2016 Results 53
Feb 01, 2016: Luminex Reports Fourth Quarter And Full Year 2015 Results 54
Product News 55
Oct 26, 2017: Vanderbilt Clinical Labs Choose VERIGENE Blood Culture Tests 55
Apr 07, 2016: Luminex to Showcase CE-IVD Marked ARIES System, Revolutionary Software, and Assays at ECCMID Annual Meeting 56
03/21/2016: Luminex Receives CE-IVD Mark for ARIES HSV 1&2 Assay 57
03/21/2016: Luminex Receives CE-IVD Mark for ARIES System 58
02/22/2016: Luminex Receives Medical Device License for ARIES HSV 1&2 Assay in Canada 59
02/22/2016: Luminex Receives Medical Device License for ARIES System in Canada 60
Product Approvals 61
Mar 21, 2016: Luminex Receives CE-IVD Mark for ARIES System 61
Mar 21, 2016: Luminex Receives CE-IVD Mark for ARIES HSV 1&2 Assay 62
Other Significant Developments 63
Aug 29, 2017: Luminex and Sutter Health Collaborate to Improve Patient Care 63
Appendix 64
Methodology 64
About GlobalData 64
Contact Us 64
Disclaimer 64

List of Tables
Luminex Corp, Medical Equipment, Key Facts, 2016 2
Luminex Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Luminex Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Luminex Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Luminex Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Luminex Corp, Deals By Market, 2011 to YTD 2017 9
Luminex Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Natural Molecular Testing Enters Into Licensing Agreement With Luminex 12
Merck Enters Into Licensing Agreement With Luminex To Develop Companion Diagnostic Device 13
Genetic Analysis Enters into Agreement with Luminex 14
Luminex Enters into Distribution Agreement with Bio-Techne 15
Affymetrix Enters into Distribution Agreement with Luminex 16
TheraDiag Enters Into Distribution Agreement With Luminex For xTAG RVP And xTAG GPP 17
Luminex Extends Distribution Agreement With EMD Millipore 18
Nanosphere Enters Into Distribution Agreement With Hitachi High-Technologies 19
Nanosphere Enters Into Co-Marketing Agreement With Thermo Fisher For Verigene Products 20
Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX 21
Luminex Enters Into Distribution Agreement With Life Technologies 22
Luminex Enters Into An Agreement With Partners HealthCare 23
Nanosphere Raises USD10 Million in Public Offering of Shares 24
Nanosphere to Raise USD4.4 Million in Private Placement of Convertible Preferred Stock 26
Nanosphere Raises USD4.4 Million in Private Placement of Series A Convertible Preferred Stock 27
Nanosphere Raises USD20 Million in Public Offering of Shares 28
Nanosphere Completes Public Offering Of Shares For US$30.2 Million 29
Nanosphere Completes Public Offering Of Shares For US$5 Million 31
Nanosphere Completes Public Offering Of Common Stock For US$29 Million 32
Nanosphere Completes Underwritten Public Offering Of US$34.5 Million 33
Luminex Plans To Sell Newborn Screening Business 35
Luminex Acquires Nanosphere in Tender Offer 36
Nanosphere Plans to Sell Itself 38
Luminex Completes Acquisition Of GenturaDx, Molecular Diagnostics Company, For Upto US$60 Million 39
Luminex Completes Acquisition Of EraGen Biosciences 41
Luminex Corp, Key Competitors 42
Luminex Corp, Key Employees 43
Luminex Corp, Other Locations 44
Luminex Corp, Subsidiaries 44

★海外企業調査レポート[Luminex Corp (LMNX)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PTC India Ltd (PTC):電力:M&Aディール及び事業提携情報
    Summary PTC India Ltd (PTC) formerly Power Trading Corporation of India Limited, is a provider of power trading solutions. The company is a public-private partnership entity initiated by the government of India. It carries out trading activities which include, long term trading of power generated fr …
  • Monex Group, Inc.:企業の戦略・SWOT・財務情報
    Monex Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Monex Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Rigaku Corporation:企業の戦略・SWOT・財務情報
    Rigaku Corporation - Strategy, SWOT and Corporate Finance Report Summary Rigaku Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • China Environmental Energy Investment Limited:企業のM&A・事業提携・投資動向
    China Environmental Energy Investment Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Environmental Energy Investment Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, …
  • Canadian Broadcasting Corp:企業の戦略的SWOT分析
    Canadian Broadcasting Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Equinix Inc (EQIX):企業の財務・戦略的SWOT分析
    Equinix Inc (EQIX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Core Laboratories NV (CLB):企業の財務・戦略的SWOT分析
    Core Laboratories NV (CLB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Berry Global Group Inc:戦略・SWOT・企業財務分析
    Berry Global Group Inc - Strategy, SWOT and Corporate Finance Report Summary Berry Global Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • ALung Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary ALung Technologies Inc (ALung Technologies) is a medical device company that develops devices for treating patients with acute respiratory failure. The company's Hemolung Respiratory Assist System(RAS) provides respiratory dialysis that removes carbon dioxide and delivers oxygen directly to …
  • New York Power Authority:企業の戦略・SWOT・財務分析
    New York Power Authority - Strategy, SWOT and Corporate Finance Report Summary New York Power Authority - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Kurabo Industries Ltd (3106):企業の財務・戦略的SWOT分析
    Kurabo Industries Ltd (3106) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Kresta Holdings Limited (KRS):企業の財務・戦略的SWOT分析
    Kresta Holdings Limited (KRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Tgb Banquets And Hotels
    Tgb Banquets And Hotels - Strategy, SWOT and Corporate Finance Report Summary Tgb Banquets And Hotels - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • SSAB AB:企業の戦略・SWOT・財務情報
    SSAB AB - Strategy, SWOT and Corporate Finance Report Summary SSAB AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Nihon Kohden Corp (6849)-医療機器分野:企業M&A・提携分析
    Summary Nihon Kohden Corp (Nihon Kohden) is a provider of medical electronic equipment to support treatment in clinical areas of emergency response; testing, diagnosis, treatment, and rehabilitation. Its major products include patient monitors, electroencephalographs, evoked potential and electromyo …
  • Vast Resources Plc:企業の戦略・SWOT・財務情報
    Vast Resources Plc - Strategy, SWOT and Corporate Finance Report Summary Vast Resources Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Natco Pharma Ltd (NATCOPHARM):製薬・医療:M&Aディール及び事業提携情報
    Summary Natco Pharma Ltd (Natco Pharma) focuses on the research, development, manufacture and commercialization of pharmaceutical substances and finished dosage forms. The company offers finished dosage forms in capsule, injection and tablet. Its products are indicated to treat multiple sclerosis, i …
  • Nexstim Plc (NXTMH):医療機器:M&Aディール及び事業提携情報
    Summary Nexstim Plc (Nexstim) focuses on navigated, non-invasive brain stimulation therapy and diagnosis based on E-field navigated neuro stimulation technology (eTMS). Its NBS system applies the technology for pre-surgical mapping of the motor and speech cortices. It is also used for research, ther …
  • Grand Haven Board of Light and Power:企業の戦略的SWOT分析
    Grand Haven Board of Light and Power - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • GW Pharmaceuticals Plc (GWP):医療機器:M&Aディール及び事業提携情報
    Summary GW Pharmaceuticals Plc (GW Pharmaceuticals) is a biopharmaceutical company that discovers, develops and commercializes novel therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, for the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆